BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37913621)

  • 1. Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
    Lin CH; Huang CJ; Lin TC; Chan HY; Chen JJ
    Psychiatry Res; 2023 Dec; 330():115575. PubMed ID: 37913621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006-2021.
    Lin TC; Lin CH
    Int J Neuropsychopharmacol; 2023 Nov; 26(11):808-816. PubMed ID: 37616565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends in clozapine use at time of discharge among people with schizophrenia at two public psychiatric hospitals in Taiwan, 2006-2017.
    Lin CH; Chan HY; Hsu CC; Chen FC
    Sci Rep; 2020 Oct; 10(1):17984. PubMed ID: 33093511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
    Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
    JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia.
    Lin CH; Chen FC; Chan HY; Hsu CC
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):23-30. PubMed ID: 31481273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
    Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
    J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with laxative use in schizophrenia patients treated with second-generation antipsychotics.
    Lin CH; Chan HY; Hsu CC; Chen FC
    Eur Neuropsychopharmacol; 2021 Feb; 43():139-146. PubMed ID: 33419642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic polypharmacy in a treatment-refractory schizophrenia population receiving adjunctive treatment with electroconvulsive therapy.
    Kristensen D; Hageman I; Bauer J; Jørgensen MB; Correll CU
    J ECT; 2013 Dec; 29(4):271-6. PubMed ID: 23859980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics.
    Lin CH; Chan HY; Hsu CC; Chen FC
    J Affect Disord; 2021 Jan; 279():292-298. PubMed ID: 33096327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Readmission Rates of Patients Discharged on Antipsychotic Polypharmacy Compared to Antipsychotic Monotherapy.
    Greer D; Parikh A; Jimenez HR
    Community Ment Health J; 2023 Apr; 59(3):507-511. PubMed ID: 36242684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
    Wu YH; Lai CY; Chang YS
    Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic polypharmacy: a needle in a haystack?
    López de Torre A; Lertxundi U; Hernández R; Medrano J
    Gen Hosp Psychiatry; 2012; 34(4):423-32. PubMed ID: 22460003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics.
    Lin CH; Chen FC; Chan HY; Hsu CC
    Int J Neuropsychopharmacol; 2019 Sep; 22(9):541-547. PubMed ID: 31260538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Chiu HF; Correll CU; Ungvari GS; Lai KY; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM
    Aust N Z J Psychiatry; 2015 Feb; 49(2):129-36. PubMed ID: 24923760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic Polypharmacy in Older Adult Asian Patients With Schizophrenia: Research on Asian Psychotropic Prescription Pattern.
    Dong M; Zeng LN; Zhang Q; Yang SY; Chen LY; Sim K; He YL; Chiu HF; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK; Ng CH; Ungvari GS; Xiang YT
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):304-311. PubMed ID: 31480982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine.
    Kitagawa K; Uekusa S; Hanai Y; Kimura I; Tsukahara M; Kagawa A; Sasaoka K; Sakishiro Y; Miyake A; Watanabe Y; Baba D; Kodama M; Kishi Y; Yamada N; Yoshio T; Matsuo K
    Asian J Psychiatr; 2024 Jun; 96():104047. PubMed ID: 38640549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation.
    Lagreula J; de Timary P; Elens L; Dalleur O
    Ther Adv Psychopharmacol; 2022; 12():20451253221112587. PubMed ID: 36051501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland.
    Jaracz J; Tetera-Rudnicka E; Kujath D; Raczyńska A; Stoszek S; Czernaś W; Wierzbiński P; Moniakowski A; Jaracz K; Rybakowski J
    Pharmacol Rep; 2014 Aug; 66(4):613-7. PubMed ID: 24948062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of antipsychotic prescriptions in patients with schizophrenia in China: A national survey.
    Wang J; Jiang F; Zhang Y; Cotes RO; Yang Y; Liu Z; Ning X; Liu T; Liu Y; Tang YL; Liu H
    Asian J Psychiatr; 2021 Aug; 62():102742. PubMed ID: 34243064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.